Home » Science Corner » Ochratoxin A Toxicosis in Economic Animal Production

Ochratoxin A Toxicosis in Economic Animal Production

By: Dr. Ko-Hua Tso, scientific expert, Dr. Bata Ltd.
Ochratoxin A Toxicosis in Economic Animal Production

1. Introduction

Ochratoxins are a group of widespread toxic secondary metabolites produced by A. niger, and Penicillium verrucosum fungi commonly found in cereal (e.g., wheat, soybeans, and coffee beans), nuts, fruits (grapes), and animal feed [1,2]. Ochratoxins incidence highly occur in South Asia, Eastern Europe, and Sub-Saharan Africa, where the climatic conditions are warm and wet, favoring the growth of toxigenic fungi [3,4]. There are twenty different types of ochratoxins, among which ochratoxin A (OTA) is the highest occurrence and most toxic for non-ruminants and humans, especially for poultry and pigs [5,6]. Ochratoxin A consists of a dihydroisocoumarin part coupled, via its 7-carboxy group, with an L-β-phenylalanine part [7]. Ochratoxin A has strong thermal stability, which induces this mycotoxin to be challenging to remove by feed processing [8]. Besides, OTA has high bioaccumulation efficiency in animal tissues, organs, and dairy products and is transferable over the food chain [9]. Furthermore, OTA often occurs with fumonisin B1(FB1) and aflatoxin B1 (AFB1) because they have similar toxigenic temperature and humidity conditions. Different studies explain that OTA and FB1, or OTA and AFBwhen given in combination, have synergistic effects on each other, causing aggravated adverse effects mainly present in nephrotoxicity in poultry and pigs [10]. In summary, feed contamination with OTA is a problem almost exclusively for monogastric livestock, mainly due to the economic losses caused by the reduction of production performances, the negative impact on animal health, and the food safety issues due to the transfer of the toxin through the food chain to humans [7].

 

2. Toxicities on Animal Production

Phenylalanine is a key moiety for OTA toxicity. This chemical structure induces phenylalanine tRNA synthase dysfunction and acts as a competitive inhibitor of carboxypeptidase A [11], which inhibits protein synthesis and furthers a series of toxicities and symptoms in animals [1,12,13]. Ochratoxin A is a nephrotoxin and a hepatotoxin, immune suppressant, potent teratogen, and carcinogen which induces poor growth performances and low egg quality in pigs and poultry [1,14]. Due to ruminal bacterial protection, ruminants have a higher tolerance to OTA than monogastric animals (e.g., pigs and poultry); among monogastric animals, birds are more sensitive than swine because of the former’s renal metabolic process. Typically, young animals are more sensitive to OTA than mature ones due to their incomplete organ development [15]. 

Nephrotoxicity is considered the most important toxicity of OTA in all the non-ruminant mammals tested so far, as well as in poultry [16]. The feed containing higher OTA concentrations has been conformed to provoke porcine spontaneous nephropathy in Bulgaria and South Africa [17,18]. For about four months, porcine feed containing more than 200 μg/kg of OTA induces nephropathy damage during the fattening period [19]. Chronic exposure to OTA in birds reduces urine quantity, phenol clearance, and impaired glomerular and proximal tubular infiltration [20]. It also affects the renal functional ability to metabolize calcium and causes lipid peroxidation in poultry [21]. In addition to the kidney, the liver is the organ most severely affected by OTA, and histological alterations include congestion, swelling, and tissue lesions [22].

Ochratoxin A accumulates in the organs and products of animals due to its high protein affinity, especially to albumin, and causes contamination carryover [13,23]. In many countries, OTA was reported in samples of muscle, milk, and eggs [24,25]. Besides, due to the high accumulation of OTA, chronic exposure to it in low doses may have higher toxicity than acute exposure in high doses for animals [26].

Table 1. The guidance values of the European Union (EU) Commission and China for ochratoxin A concentrations (μg/kg) in complete feed [27-29].

Animal Species

EU

China

Swine

50

100

Poultry

100

100

Ruminants

 

 

Calf, lamb and lactating ruminants

250

100

Others

250

100

2.1  Swine

Swine is the more susceptible animal to OTA exposure as compared to ruminants. Ochratoxin A is nephrotoxic, hepatotoxic, immunotoxic, teratogenic, and neurotoxic in each stage of swine [30,31]. Ochratoxin A-acute toxicity affects the kidneys most, causing nephropathy by damaging proximal tubules in pigs [17]. Ochratoxin A is considered to be the most important mycotoxin provoking mycotoxic porcine nephropathy (MPN) [32], which is a widely encountered renal disease all over the world, such as famous Danish porcine nephropathy and Bulgarian porcine nephropathy [17,18]. The porcine gastrointestinal tract absorbs 65% of OTA after consuming the OTA-contaminated feed [33], and OTA accumulation occurs in several tissues (primarily in kidneys), leading to clinical symptoms, such as depression and reduction in feed intake, with consequent body weight loss, followed by dehydration, diarrhea, polyuria, and polydipsia, ultimately to death [34,35]. The equation slope from review research indicates an average reduction of 12% in weight gain of pigs for an increase of 1 mg/kg of OTA in the diet [7]. After necropsy of sick pigs, it will be found that enlargement of renal lymph nodes, neoplastic changes, significantly enlarged and pale appearance of kidneys as well as fibrotic changes in the cortex of the kidneys [36]. 

For reproductive ability, OTA with high concentration affects sperm production and boar semen quality [37], on the contrary, the reproductive tract of sows showed no obvious abnormalities either in the adult or the embryo [38]. Moreover, OTA also alternates some metabolism and is revealed by several anomalous serum blood parameters such as hyperproteinemia, azotemia, hypocholesterolemia, and hypercalcemia, which may indirectly affect growth performance and production ability in swine [39]. Besides, OTA induces immunosuppression, making Brachyspira hyodysenteriae and porcine circovirus type 2 (PCV2) infections in pigs [40]. 

It should be noted, because of the stability of OTA and its long half-life in blood and tissues, pigs ingesting feed containing OTA causes the latter to remain in pork and some edible tissues of pigs [14]. This may represent a potential danger to the human food chain. Indeed, the occurrence of OTA in lard, pork, blood, and liver has been extensively documented as well [14,41]. 2 

Table 2. Toxic concentrations and symptoms of ochratoxin A (OTA) in pig

Animal

OTA level (μg/kg)

Exposure time 

Effects

Reference

Piglet, 14.8 kg

500

3 weeks

Reduction body weight gain (BWG); 

abnormal blood parameters: higher serum urea and creatinine; hypocholesterolemia and hypercalcemia

[39]

Fattening 

25 

17 weeks

 

Significant reduction in body weight gain (BWG) and feed efficiency; kidneys and liver presented visible lesions and a serious hemorrhagic condition

[42]

Fattening,

8 weeks-old

800

1 year

 

Decreased BWG; swollen and pale kidneys

[43]

Boar

20

5 weeks

Reduction of sperm motility and longivity

[44]

2.2  Poultry

Ochratoxin A is one of the most toxic mycotoxins in poultry, which is more sensitive than swine [45,46]. Poultry has a lower absorption rate for OTA, which can be carried to the hindgut (mainly in the proximal jejunum) and alter with beneficial intestinal microbiota [47]. Previous research indicated that the populations of the beneficial species Lactobacillus declined in chickens exposed to OTA [45]. Besides, OTA reduced the abundance of cecum microbiota in ducks, particularly Bacteroides, and triggered intestinal injuries [48]. The physiological symptoms of OTA toxicity in poultry are weakness, anemia, reduced feed consumption, decreased productivity, reduced egg-laying, poor feathers, and excessive mortality at high dietary concentrations [49,50]. Although OTA induces alterations in internal organs such as pale swollen kidneys and enlarged yellowish livers in poultry [1,51], however, OTA is more a nephrotoxin than a hepatotoxin for poultry [52]. Nephrotoxicity of OTA also directly affects these adverse effects on production performance in broiler and laying hens.

Poultry exposed to OTA-contaminated feed becomes more prone to parasitic diseases and secondary bacterial infections, and this happens due to immunosuppression along with nephrotoxicity induced by OTA [53]. A previous study reported an increased incidence of acute enteritis in birds given OTA-contaminated feed [54]. Poultry feed containing OTA also increases the chances of air sacculitis as a secondary infection of E. coli in turkeys [55]. The immunosuppression, growth reduction, and other OTA-associated alterations make the poultry more compromised and prone to other bacterial infections. In such cases, the secondary infections become much more aggravated than those observed in birds receiving feed without OTA. Previous scientists reported an enhanced Salmonella infection when co-administered with OTA [56]. Similarly, OTA administration in birds also aggravates different viruses induced infections, as observed alongside the inclusion body hepatitis (IBH) virus [57].

Regarding reproductive toxicities, teratogenic effects were reported in many animal studies, including chicks and quails with craniofacial abnormalities and reduced birth weight being the most common [5,38]. It has been observed with great concern that eggs laid by the hens fed on OTA-contaminated feed contain their residues which are severe threats to developing embryos as these residues can cause embryonic deaths [58], reduced hatchability percentage, and poor performance/immune status of those hatched. 

Table 3. Toxic concentrations and symptoms of ochratoxin A (OTA) in poultry

Animal

OTA level (μg/kg)

Exposure time 

Effects

Reference

Broiler chicks 

≥ 100 

≥ 4 weeks

 

Decreased body weight (BW), feed intake (FI), serum protein and albumin levels; increased feed conversion ratio (FCR)

[50]

Broiler chicks

≥ 400

≥ 5 weeks

 

Decreased BW and FI; increased FCR; liver and kidney enlargement (especially in kidney); decreased gizzard, spleen, bursa, and thymus weights

[51,59,60]

Laying hens

≥ 500

≥ 6 weeks

 

Decreased egg production

[61]

Laying hens

≥ 2000

≥ 4 weeks

 

Decreased egg production, fertility, hatchability, and egg qualities (eggshell thickness, albumin index, and Haugh units)

[61,62] 

2.3 Ruminants 

Ruminants (such as cattle, sheep, and goats) are able to degrade OTA to the virtually non-toxic ochratoxin α (OTα) in the rumen mainly through the action of protozoa, thus rendering acute poisoning an infrequent event under field conditions [7,63]. An in vitro experiment concluded that cows may degrade OTA in feeds contaminated with up to 12 mg/kg [64]. Such high levels of OTA are extremely rare in the diets of general ruminant farms. In some extreme experiment conditions, higher doses of OTA (e.g., 13 mg/kg) produced clinical symptoms (e.g., anorexia, diarrhea, and difficulty in rising and rapid decrease of milk production), while the lower dose of OTA ranging from 0.2 to 1.66 mg/kg showed no clinical symptoms [65]. However, such ability is strictly related to rumen functionality. According to some experiment results, the ability of sheep to degrade OTA in its rumen is lower than that observed in cattle. Besides, pre-ruminating calves are more sensitive to OTA toxicities because they lack a developed rumen with a functional microbial population [15], thus leading to the death of calves within 24 hours from an administration by a stomach tube of a single dose of 11 mg OTA/kg body weight [16,66]. Besides, intravenous infusion of OTA at 1 mg/kg of body weight caused the death of ewes within 24 hours [7,67]. Even though ochratoxicosis has been rarely reported in ruminants, the long-term accumulation of OTA in blood and tissues represents a potential risk of its harmful effects in cattle. Therefore, the best way to prevent the adverse effects of OTA is to minimize its intake in ruminant production. 

Table 4. Ochratoxin A (OTA) toxicities on growth performance in ruminants

Animal

OTA level (μg/kg)   

Exposure time (d)

Effects

Reference

Sheep, 50 kg

14

31

No overt illness or negative effects on growth performance; traces of OTA and OTα in blood

[68]

Lactating cattle, 500 kg

200

4

No overt illness; traces of OTαin urine and milk

[16]

Pregnant lactating cattle, 500 kg

1660 

5

Delivery of normal calves; Traces of OTα in urine and milk

[16]

3. References

1. Liu, W.C.; Pushparaj, K.; Meyyazhagan, A.; Arumugam, V.A.; Pappuswamy, M.; Bhotla, H.K.; Baskaran, R.; Issara, U.; Balasubramanian, B.; Mousavi Khaneghah, A. Ochratoxin A as an alarming health threat for livestock and human: A review on molecular interactions, mechanism of toxicity, detection, detoxification, and dietary prophylaxis. Toxicon 2022213, 59-75, doi:10.1016/j.toxicon.2022.04.012.

2. Cervini, C.; Verheecke-Vaessen, C.; Ferrara, M.; Garcia-Cela, E.; Magista, D.; Medina, A.; Gallo, A.; Magan, N.; Perrone, G. Interacting climate change factors (CO2 and temperature cycles) effects on growth, secondary metabolite gene expression and phenotypic ochratoxin A production by Aspergillus carbonarius strains on a grape-based matrix. Fungal Biol 2021125, 115-122, doi:10.1016/j.funbio.2019.11.001.

3. Nguyen, M.T.; Tozlovanu, M.; Tran, T.L.; Pfohl-Leszkowicz, A. Occurrence of aflatoxin B1, citrinin and ochratoxin A in rice in five provinces of the central region of Vietnam. Food Chemistry 2007105, 42-47, doi:https://doi.org/10.1016/j.foodchem.2007.03.040.

4. Gruber-Dorninger, C.; Jenkins, T.; Schatzmayr, G. Global Mycotoxin Occurrence in Feed: A Ten-Year Survey. Toxins (Basel) 201911, doi:10.3390/toxins11070375.

5. Heussner, A.H.; Bingle, L.E. Comparative Ochratoxin Toxicity: A Review of the Available Data. Toxins (Basel)20157, 4253-4282, doi:10.3390/toxins7104253.

6. Streit, E.; Schatzmayr, G.; Tassis, P.; Tzika, E.; Marin, D.; Taranu, I.; Tabuc, C.; Nicolau, A.; Aprodu, I.; Puel, O., et al. Current situation of mycotoxin contamination and co-occurrence in animal feed--focus on Europe. Toxins (Basel) 20124, 788-809, doi:10.3390/toxins4100788.

7. Battacone, G.; Nudda, A.; Pulina, G. Effects of ochratoxin a on livestock production. Toxins (Basel) 20102, 1796-1824, doi:10.3390/toxins2071796.

8. Awuchi, C.G.; Ondari, E.N.; Ogbonna, C.U.; Upadhyay, A.K.; Baran, K.; Okpala, C.O.R.; Korzeniowska, M.; Guine, R.P.F. Mycotoxins Affecting Animals, Foods, Humans, and Plants: Types, Occurrence, Toxicities, Action Mechanisms, Prevention, and Detoxification Strategies-A Revisit. Foods 202110, doi:10.3390/foods10061279.

9. Denli, M.; Perez, J.F. Ochratoxins in feed, a risk for animal and human health: control strategies. Toxins (Basel) 20102, 1065-1077, doi:10.3390/toxins2051065.

10. Verma, J.; Johri Ts Fau - Swain, B.K.; Swain Bk Fau - Ameena, S.; Ameena, S. Effect of graded levels of aflatoxin, ochratoxin and their combinations on the performance and immune response of broilers.

11. Pitout, M.J.; Nel, W. The inhibitory effect of ochratoxin A on bovine carboxypeptidase A in vitro. Biochem Pharmacol 196918, 1837-1843, doi:10.1016/0006-2952(69)90279-2.

12. Zanic-Grubisic, T.; Zrinski, R.; Cepelak, I.; Petrik, J.; Radic, B.; Pepeljnjak, S. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine. Toxicol Appl Pharmacol 2000167, 132-139, doi:10.1006/taap.2000.8987.

13.  Stoev, S.D.; Gundasheva, D.; Zarkov, I.; Mircheva, T.; Zapryanova, D.; Denev, S.; Mitev, Y.; Daskalov, H.; Dutton, M.; Mwanza, M., et al. Experimental mycotoxic nephropathy in pigs provoked by a mouldy diet containing ochratoxin A and fumonisin B1. Exp Toxicol Pathol 201264, 733-741, doi:10.1016/j.etp.2011.01.008.

14. Vlachou, M.; Pexara, A.; Solomakos, N.; Govaris, A. Ochratoxin A in Slaughtered Pigs and Pork Products. Toxins (Basel) 202214, doi:10.3390/toxins14020067.

15. Mobashar, M.; Hummel, J.; Blank, R.; Sudekum, K.H. Ochratoxin A in ruminants-A review on its degradation by gut microbes and effects on animals. Toxins (Basel) 20102, 809-839, doi:10.3390/toxins2040809.

16. Ribelin, W.E.; Fukushima, K.; Still, P.E. The toxicity of ochratoxin to ruminants. Can J Comp Med 197842, 172-176.

17. Stoev, S.D.; Dutton, M.F.; Njobeh, P.B.; Mosonik, J.S.; Steenkamp, P.A. Mycotoxic nephropathy in Bulgarian pigs and chickens: complex aetiology and similarity to Balkan endemic nephropathy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 201027, 72-88, doi:10.1080/02652030903207227.

18. Stoev, S.D.; Denev, S.; Dutton, M.F.; Njobeh, P.B.; Mosonik, J.S.; Steenkamp, P.A.; Petkov, I. Complex etiology and pathology of mycotoxic nephropathy in South African pigs. Mycotoxin Res 201026, 31-46, doi:10.1007/s12550-009-0038-7.

19. Krogh, P.; Axelsen, N.H.; Elling, F.; Gyrd-Hansen, N.; Hald, B.; Hyldgaard-Jensen, J.; Larsen, A.E.; Madsen, A.; Mortensen, H.P.; Moller, T., et al. Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta Pathol Microbiol Scand Suppl 19740, 1-21.

20. Huff, W.E.; Wyatt, R.D.; Hamilton, P.B. Nephrotoxicity of dietary ochratoxin A in broiler chickens. Appl Microbiol 197530, 48-51, doi:10.1128/am.30.1.48-51.1975.

21. Khatoon, A.; ul Abidin, Z. An extensive review of experimental ochratoxicosis in poultry: II. Hemato-biochemical and immunological alterations along with other health issues. Toxin Reviews 201940, 361-369, doi:10.1080/15569543.2019.1614065.

22. Abidin, Z.u.; Khan, M.Z.; Khatoon, A.; Saleemi, M.K.; Khan, A. Protective effects of l-carnitine upon toxicopathological alterations induced by ochratoxin A in white Leghorn cockerels. Toxin Reviews 201635, 157-164, doi:10.1080/15569543.2016.1219374.

23. Zhao, Z.; Liu, N.; Yang, L.; Deng, Y.; Wang, J.; Song, S.; Lin, S.; Wu, A.; Zhou, Z.; Hou, J. Multi-mycotoxin analysis of animal feed and animal-derived food using LC-MS/MS system with timed and highly selective reaction monitoring. Anal Bioanal Chem 2015407, 7359-7368, doi:10.1007/s00216-015-8898-5.

24. Tangni, E.K.; Masquelier, J.; Van Hoeck, E. Determination of ochratoxin A in edible pork offal: intra-laboratory validation study and estimation of the daily intake via kidney consumption in Belgium. Mycotoxin Res 202137, 79-87, doi:10.1007/s12550-020-00415-7.

25. Pleadin, J.; Kudumija, N.; Kovacevic, D.; Scortichini, G.; Milone, S.; Kmetic, I. Comparison of ochratoxin A levels in edible pig tissues and in biological fluids after exposure to a contaminated diet. Mycotoxin Res 201632, 145-151, doi:10.1007/s12550-016-0249-7.

26. Pfohl-Leszkowicz, A. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 200960, 465-483, doi:10.2478/10004-1254-60-2009-2000.

27. Park, D.L.; Troxell, T.C. U.S. perspective on mycotoxin regulatory issues.

28. Commission, E. Commission recommendation of of 17 august 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin a, T-2 and HT-2 and fumonisins in products intended for animal feeding. Commission, E., Ed. Official Journal of the European Union: 2006.

29. General Administration of Quality Supervision, I.a.Q.o.t.P.s.R.o.C.a.S.A.o.t.P.s.R.o.C. Hygienic Standard for Feeds GB13078-2017. General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China and Standardization Administration of the People's Republic of China: 2018.

30. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Malir, J.; Toman, J. Ochratoxin A: 50 Years of Research. Toxins (Basel) 20168, doi:10.3390/toxins8070191.

31. Stoev, S.D. Foodborne mycotoxicoses, risk assessment and underestimated hazard of masked mycotoxins and joint mycotoxin effects or interaction. Environ Toxicol Pharmacol 201539, 794-809, doi:10.1016/j.etap.2015.01.022.

32. Stoev, S.D.; Denev, S.A. Porcine/chicken or human nephropathy as the result of joint mycotoxins interaction. Toxins (Basel) 20135, 1503-1530, doi:10.3390/toxins5091503.

33. Anzai, N.; Jutabha, P.; Endou, H. Molecular mechanism of ochratoxin a transport in the kidney. Toxins (Basel) 20102, 1381-1398, doi:10.3390/toxins2061381.

34. Marin, D.E.; Braicu, C.; Gras, M.A.; Pistol, G.C.; Petric, R.C.; Berindan Neagoe, I.; Palade, M.; Taranu, I. Low level of ochratoxin A affects genome-wide expression in kidney of pig. Toxicon 2017136, 67-77, doi:10.1016/j.toxicon.2017.07.004.

35. Szczech, G.M.; Carlton, W.W.; Tuite, J.; Caldwell, R. Ochratoxin A toxicosis in swine. Vet Pathol 197310, 347-364, doi:10.1177/030098587301000408.

36. Friis, C.; Brinn, R.; Hald, B. Uptake of ochratoxin A by slices of pig kidney cortex. Toxicology 198852, 209-217, doi:10.1016/0300-483x(88)90205-3.

37. Biro, K.; Barna-Vetro, I.; Pecsi, T.; Szabo, E.; Winkler, G.; Fink-Gremmels, J.; Solti, L. Evaluation of spermatological parameters in ochratoxin A--challenged boars. Theriogenology 200360, 199-207, doi:10.1016/s0093-691x(02)01375-4.

38. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Novotna, E. Ochratoxin A: developmental and reproductive toxicity-an overview. Birth Defects Res B Dev Reprod Toxicol 201398, 493-502, doi:10.1002/bdrb.21091.

39. Lippold, C.C.; Stothers, S.C.; Frohlich, A.A.; Boila, R.J.; Marquardt, R.R. Effects of periodic feeding of diets containing ochratoxin A on the performance and clinical chemistry of pigs from 15 to 50 kg body weight. Canadian Journal of Animal Science 199272, 135-146, doi:10.4141/cjas92-015.

40. Pierron, A.; Alassane-Kpembi, I.; Oswald, I.P. Impact of mycotoxin on immune response and consequences for pig health. Anim Nutr 20162, 63-68, doi:10.1016/j.aninu.2016.03.001.

41. Streit, B.; Czabany, T.; Weingart, G.; Marchetti-Deschmann, M.; Prasad, S. Toolbox for the Extraction and Quantification of Ochratoxin A and Ochratoxin Alpha Applicable for Different Pig and Poultry Matrices. Toxins (Basel) 202214, doi:10.3390/toxins14070432.

42. Magnoli, C.; Hallak, C.; Astoreca, A.; Ponsone, L.; Chiacchiera, S.M.; Palacio, G.; Dalcero, A. Surveillance of toxigenic fungi and ochratoxin A in feedstuffs from Cordoba Province, Argentina. Vet Res Commun 200529, 431-445, doi:10.1007/s11259-005-5507-7.

43. Stoev, S.D.; Paskalev, M.; MacDonald, S.; Mantle, P.G. Experimental one year ochratoxin A toxicosis in pigs. Exp Toxicol Pathol 200253, 481-487, doi:10.1078/0940-2993-00213.

44. Solti, L.; Pecsi, T.; Barna-Vetro, I.; Szasz, F., Jr.; Biro, K.; Szabo, E. Analysis of serum and seminal plasma after feeding ochratoxin A with breeding boars. Anim Reprod Sci 199956, 123-132, doi:10.1016/s0378-4320(99)00032-9.

45. Zhai, S.; Zhu, Y.; Feng, P.; Li, M.; Wang, W.; Yang, L.; Yang, Y. Ochratoxin A: its impact on poultry gut health and microbiota, an overview. Poult Sci 2021100, 101037, doi:10.1016/j.psj.2021.101037.

46. Bozzo, G.; Pugliese, N.; Samarelli, R.; Schiavone, A.; Dimuccio, M.M.; Circella, E.; Bonerba, E.; Ceci, E.; Camarda, A. Ochratoxin A and Aflatoxin B1 Detection in Laying Hens for Omega 3-Enriched Eggs Production. In Agriculture, 2023; Vol. 13.

47. Galtier, P.; Alvinerie, M.; Charpenteau, J.L. The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food Cosmet Toxicol 198119, 735-738, doi:10.1016/0015-6264(81)90528-9.

48. Zhai, S.S.; Ruan, D.; Zhu, Y.W.; Li, M.C.; Ye, H.; Wang, W.C.; Yang, L. Protective effect of curcumin on ochratoxin A–induced liver oxidative injury in duck is mediated by modulating lipid metabolism and the intestinal microbiota. Poultry Science 202099, 1124-1134, doi:https://doi.org/10.1016/j.psj.2019.10.041.

49. Murugesan, G.R.; Ledoux, D.R.; Naehrer, K.; Berthiller, F.; Applegate, T.J.; Grenier, B.; Phillips, T.D.; Schatzmayr, G. Prevalence and effects of mycotoxins on poultry health and performance, and recent development in mycotoxin counteracting strategies. Poult Sci 201594, 1298-1315, doi:10.3382/ps/pev075.

50. Sakthivelan, S.M.; Sudhakar Rao, G.V. Effect of ochratoxin a on body weight, feed intake and feed conversion in broiler chicken. Vet Med Int 20102010, 590432, doi:10.4061/2010/590432.

51. Elaroussi, M.A.; Mohamed, F.R.; Elgendy, M.S.; Barkouky, E.M.E.; Abdou, A.M.; Hatab, M.H. Ochratoxicosis in Broiler Chickens: Functional and Histological Changes in Target Organs. International Journal of Poultry Science 20087, 414-422, doi:10.3923/ijps.2008.414.422.

52. Kumar, A.; Jindal, N.; Shukla, C.L.; Asrani, R.K.; Ledoux, D.R.; Rottinghaus, G.E. Pathological changes in broiler chickens fed ochratoxin A and inoculated with Escherichia coli. Avian Pathol 200433, 413-417, doi:10.1080/03079450410001724021.

53. Stoev, S.D.; Djuvinov D Fau - Mirtcheva, T.; Mirtcheva T Fau - Pavlov, D.; Pavlov D Fau - Mantle, P.; Mantle, P. Studies on some feed additives giving partial protection against ochratoxin A toxicity in chicks.

54. Fukata, T.; Sasai, K.; Baba, E.; Arakawa, A. Effect of ochratoxin A on Salmonella typhimurium-challenged layer chickens. Avian Dis 199640, 924-926.

55. Hamilton Pb Fau - Huff, W.E.; Huff We Fau - Harris, J.R.; Harris Jr Fau - Wyatt, R.D.; Wyatt, R.D. Natural occurrences of ochratoxicosis in poultry.

56. Elissalde, M.H.; Ziprin, R.L.; Huff, W.E.; Kubena, L.F.; Harvey, R.B. Effect of ochratoxin A on Salmonella-challenged broiler chicks. Poult Sci 199473, 1241-1248, doi:10.3382/ps.0731241.

57. Sandhu, B.S.; Singh, H.; Singh, B. Pathological studies in broiler chicks fed aflatoxin or ochratoxin and inoculated with inclusion body hepatitis virus singly and in concurrence. Vet Res Commun 199519, 27-37, doi:10.1007/BF01839249.

58. Gilani, S.H.; Bancroft, J.; Reily, M. Teratogenicity of ochratoxin A in chick embryos. Toxicol Appl Pharmacol 197846, 543-546, doi:10.1016/0041-008x(78)90099-6.

59. Elaroussi, M.A.; Mohamed, F.R.; El Barkouky, E.M.; Atta, A.M.; Abdou, A.M.; Hatab, M.H. Experimental ochratoxicosis in broiler chickens. Avian Pathol 200635, 263-269, doi:10.1080/03079450600817115.

60. Hanif, N.Q.; Muhammad, G.; Siddique, M.; Khanum, A.; Ahmed, T.; Gadahai, J.A.; Kaukab, G. Clinico-pathomorphological, serum biochemical and histological studies in broilers fed ochratoxin A and a toxin deactivator (Mycofix Plus). Br Poult Sci 200849, 632-642, doi:10.1080/00071660802295183.

61. Giancarlo, B.; Elisabetta, B.; Edmondo, C.; Valeriana, C.; Giuseppina, T. Determination of ochratoxin A in eggs and target tissues of experimentally drugged hens using HPLC–FLD. Food Chemistry 2011126, 1278-1282, doi:https://doi.org/10.1016/j.foodchem.2010.11.070.

62. Zaghini, A.; Simioli, M.; Roncada, P.; Rizzi, L. Effect of Saccharomyces cerevisiae and esterified glucomannan on residues of Ochratoxin A in kidney, muscle and blood of laying hens. Ital J Anim Sci 20076, 737-739, doi:10.4081/ijas.2007.1s.737.

63. Wu, Q.; Dohnal, V.; Huang, L.; Kuca, K.; Wang, X.; Chen, G.; Yuan, Z. Metabolic pathways of ochratoxin A. Curr Drug Metab 201112, 1-10, doi:10.2174/138920011794520026.

64. Hult, K.; Teiling, A.; Gatenbeck, S. Degradation of ochratoxin A by a ruminant. Appl Environ Microbiol 197632, 443-444, doi:10.1128/aem.32.3.443-444.1976.

65. Kemboi, D.C.; Antonissen, G.A.-O.; Ochieng, P.E.; Croubels, S.A.-O.; Okoth, S.A.-O.; Kangethe, E.K.; Faas, J.; Lindahl, J.F.; Gathumbi, J.K. A Review of the Impact of Mycotoxins on Dairy Cattle Health: Challenges for Food Safety and Dairy Production in Sub-Saharan Africa. LID - 10.3390/toxins12040222 [doi] LID - 222.

66. Sreemannarayana, O.; Frohlich, A.A.; Vitti, T.G.; Marquardt, R.R.; Abramson, D. Studies of the tolerance and disposition of ochratoxin A in young calves. J Anim Sci 198866, 1703-1711, doi:10.2527/jas1988.6671703x.

67. Harwig, J.; Munro, I.C. Mycotoxins of possible importance in diseases of Canadian farm animals. Can Vet J 197516, 125-141.

68. Blank, R.; Rolfs, J.-P.; Südekum, K.-H.; Frohlich, A.A.; Marquardt, R.R.; Wolffram, S. Effect of roughage:concentrate ratio in the diet on systemic availability and excretion of ochratoxin A in sheep. Journal of Animal and Feed Sciences 200413, 673-676, doi:10.22358/jafs/74087/2004.

back